Rabbit anti-glomerular basement membrane serum (AGBM) or normal rabbit serum (NRS) were given intravenously (2 mVkg body weight) to 8 male beagle dogs. Light and transmission electron microscopy and immunofluorescence were performed on the kidneys on day 7 postinjection. Alterations of anionic sites (ASS) of glomerular basement membrane (GBM) in peripheral, proximal, and paramesangial portions were studied quantitatively by electron microscopy using polyethyleneimine (PEI; molecular weight = 1,800) as a cationic probe. Severe or mild proteinuria developed on day 1 and continued until day 6 postinjection. On day 7 after AGBM injection, the number of PEI granules per 1,000 nm length of the lamina rara externa of GBM in all portions was significantly less than that in NRS-treated dogs (10.48 -C 1.78 versus 14.19 f 2.35 granules per 1,000 nm of GBM in peripheral portion, 10.81 f 1.91 versus 14.97 2 1.35 granules per 1,000 nm of GBM in proximal portion, 8.44 k 1.76 vs 13.43 f 2.10 granules per 1,000 nm of GBM in paramesangial portion; p < 0.001). These results indicate that a reduction glomerular AS occurs in AGBM-treated dogs in association with severe or mild proteinuria and alterations in glomerular ASS might play an important role in the pathogenesis of proteinuria in the canine anti-GBM nephritis in addition to morphological changes.
INTRODUCTION
Recent studies have indicated that anionic charge in the glomerular basement membrane (GBM) is important for ultrafiltration in the renal glomeruli (7, 25, 30, 31, 34) . To date, there have been few studies on canine nephrotoxic glomerulonephritis produced by anti-GBM serum (AGBM; 27, 35) . These studies have dealt with morphologic changes only; the charge properties of GBM have not been studied in this model. In the present study, glomerulonephritis with onset of severe proteinuria was induced by administration ofAGBM in dogs, and the glomerular anionic sites (ASS) were observed by electron microscopy to ascertain the relationship between proteinuria and alteration of ASS in this model.
METHODS
Preparation of GBM Antigen. GMBs were prepared from the perfused kidneys of young beagle dogs by the method of Krisko et a1 (1 5 ) as modified 316 by Shirota and Fujiwara (27) . The kidneys were decapsulated and the cortices were finely minced. The minced tissue was forced through 600-, 250-, 177-, and 125-pm pore-sized stainless-steel sieves with large amounts of cold physiological saline (PS). The material retained on the 125-pm pore-sized sieve was sonicated for 9 min and then allowed to pass through a 74-pm pore-sized mesh. The sample retained on this sieve was rich in glomeruli and sonicated for 30 min to disrupt the GBM. The resultant suspension was then lyophilized and stored at -25°C until used.
Preparation of AGBM. Male albino rabbits weighing about 3 kg were injected into the footpads with 60 mg of lyophilized GBM suspended in PS and emulsified in complete Freund's adjuvant. One mo later, a booster injection of the same amount of antigen was given subcutaneously without adjuvant, and the animals were bled 14 days later. The sera were then pooled, decomplemented, and absorbed twice with freshly harvested dog red blood cells.
The specificity of AGBM was tested by indirect immunoperoxidase method with DAB as the chromogen. Paraffin sections of normal dog kidney were exposed to AGBM for 30 min at room temperature.
After washing in phosphate-buffered saline (PBS), sections were stained with sheep anti-rabbit IgG antibody conjugated with peroxidase (Bethyl Laboratories, Inc., USA).
Indiiction of Experiiiierital Nephritis. Eight young male dogs aged 12 wk, weighing approximately 5 kg, were used. Two groups of 4 animals each were given AGBM or normal rabbit serum (NRS) intravenously at a dosage of 2 ml/kg body weight. The schedule for urinalysis and pathological examinations are shown in Table I .
Urinalysis. The protein content of 15-hr urine collections was measured using the Ponceau S dye method (20) . The protein content in each group was estimated by Wilcoxon rank sum test for nonpaired observations. Any cited difference is significant at the 5% level or less.
Tissue Preparations. For light microscopy, kidneys were fixed in 10% neutral-buffered formalin and embedded in paraffin, and 2%pm sections were cut and stained with hematoxylin and eosin (H&E). Immuno staining of heparan sulfate proteoglycan (HSPG) was performed using the peroxidase-antiperoxidase (PAP) method with DAB as the chromogen. Paraffin sections were incubated with mouse anti-HSPG monoclonal antibody (Chemicon International Inc., CA) at room temperature for 1 hr. For immunofluorescence microscopy, small samples of kidneys were frozen in hexane-dry ice acetone. Cryostat sections were cut and stained for 1 hr with fluorescein isothiocyanate-conjugated antibodies, goat anti-rabbit IgG (Organon Teknika N. V.-Cappel products, West Chester, PA), sheep anti-dog IgG, or sheep anti-dog complement (C3) sera (The Binding Site Ltd., Birmingham, UK). After washing in PBS for 20 min, sections were examined using a fluorescence microscope (Nikon Ltd., Japan).
Ultrastructural Study for ASS. Staining of ASS with polyethyleneimine (PEI; molecular weight = 1,800; IPolysciences, Wamngton, PA) was performed;by a minor modification of the method of Schurer et al. (26) . Freshly sampled renal cortex was cut into 0.5-mm3 pieces and immersed in 0.5% PEI in PS for 30 min at room temperature. After washing in 0.2 M cacodylate buffer (CB), pH 7.4,400 mOsm, the blocks were reimmersed in the solution containing 2% phosphotungstic acid (PTA) and 0.1% glutaraldehyde (GA), pH 7.4,400 mOsm at 4°C for I hr to obtain insoluble precipitates of PEI bound to glomerular ASS. After washing 3 times for 10 min in CB, the blocks were postfixed in 2% osmium tetraoxide in CB at 4°C for 2 hr. Then, the blocks were dehydrated in graded ethanol and embedded in Quetol-8 12 (Nisshin EM, Tokyo). Ultrathin sections were cut and stained with uranyl acetate and lead citrate and examined in a Hitachi-7000 trans- mission electron microscope (Hitachi, Ltd., Tokyo). The PEI solution was adjusted to pH 7.4 with HCl and to 400 mOsm with sucrose. The mixture of 2% PTA and 0.1% GA was prepared within 2 hr before use (osmolality adjusted to 400 mOsm with sucrose and pH adjusted to 7.4 with concentrated KOH solution).
Morphoinetric Analysis of Ass. For the quantitative analysis of ASS in different portions of the GBM, the ASS were counted within the lamina rara externa (LRE) and lamina rara interna (LRI) of the capillary walls and the LRE of the paramesangial region, and a total of 3040 portions in 3 4 glomeruli were observed on each dog. Specimens were photographedat a magnification of x 7,000 and then printed at a final magnification of ~28,000. The values of ASS were expressed as the mean number of granules per 1,000 nm length of GBM. That portion of the glomerular capillary wall, 7,000 nm or more from the anchor portion, was considered to be the peripheral portion. The length within 3,000 nm from the anchor portion was regarded as the proximal portion, and the portion of the basement membrane surrounding the mesangial area was considered to be the paramesangial portion (Fig. 2) . The mean number of PEI granules in each portion in the 2 groups was estimated by the Student's t-test for nonpaired observations. Any cited difference is significant at the 5% level or less.
RESULTS

Specificity of AGBM
The AGBM was shown to react with the glomerular capillary wall of normal dog kidney in a linear pattern ( Fig. 1 ). No positive reaction was observed in the tubular basement membrane and vascular basement membrane in the interstitium.
Urinalysis
Results are summarized in Fig. 3 . Severe or mild proteinuria developed on day 1 and continued until day 6. The degree of proteinuria peaked on day 5. Electron-dense granules of PEI were distributed regularly in the LRE of the GBM. However, the ASS distributed irregularly in the LRI and much less in number than those seen within the LRE (Fig. 4) . The number of ASS in the LRE of all 3 GBM portions was significantly reduced in the AGBM-treated group as compared with the NRS-treated group on day 7. The ASS in the LRE at the portions with fusion of epithelial foot processes were compared with those in the LRE without fusion. No significant differences were seen in the number of ASS in the LRE at 2 different sites. The number of PEI granules of the LRT in both the peripheral and proximal portions also significantly decreased in the AGBMtreated group on day 7 (Table I1 and Fig. 4 ).
Pathological Examination
Light Microscopy. Intense swelling and hypercellularity of the glomeruli, resulting in occlusion of the urinary space and capillary lumens, was seen in the AGBM-treated dogs on day 7. Extensive necrosis with fibrinous deposits in the glomerulus was detected in the extra-and intracapillary sites (Fig.  5) . Proliferation of parietal epithelium, resulting in crescentic formation, occurred in most glomeruli. In some glomeruli, the capillary tuft adhered to Bowman's capsule. By the immunoperoxidase method, staining of HSPG on the GBM in AGBMtreated dogs was comparable to that in NRS-treated dogs on day 7 (Fig. 6 ).
I m 111 iinofluorescence. Striking linear deposition
of rabbit IgG was found along the glomerular capillary walls of AGBM-treated dogs on day 7 (Fig.  7) . Fluorescence for dog IgG was less bright, with a focal segmental distribution (Fig. 8) . Discontinuous linear and focal granular deposition of dog C3 was detected along the glomerular capillary walls on day 7 (Fig. 9) .
Electroii Microscopy. On day 7 postinjection, the GBM was irregularly swollen and sometimes laminated. The swollen GBM sometimes showed areas of a loose texture and fusion of epithelial foot processes ( Fig. 10 ).
DISCUSSION
In this study, administration of AGBM resulted in glomerulonephritis with the onset of severe proteinuria. On day 7, there were extensive glomerular lesions such as necrosis, swelling, hypercellularity, cresent formation, and capsular adhesion, which were in accord with those of previously reported studies on nephrotoxic glomerular nephritis (3-6, 8, 9, 13, 14, 19, 21, 24, 28) including those in dogs (27, 35) .
In AGBM-treated dogs with severe or mild proteinuria, a loss of glomerular ASS was evidenced.
Thus, the proteinuria we observed in this study was associated with a decrease in ASS in GBMs, as have been noted in other.rena1 diseases (1 , 2, 18, 23, 25, 29,32,34) . In contrast, in a rat model of puromycin aminonucleoside (PAN) neprosis, AS distributions in the GBM did not change significantly (7). Hence, it has been suggested that the proteinuria of disease is not related to the decreased ASS of the GBM (7, 16,3 1). The differences in the results presented here might have a possible explanation. Various cationic probes have been used to stain glomerular ASS, including ruthenium red and cationic ferritin (1 1) and PEI (26) . Potential differences in penetrability of polymers and small molecules with different isoelectric points, the method of administrating the probe, and the incubation time in the probe have complicated interpretation ofresults obtained in different laboratories (7, 16, 17, 22, 31, 33) .
The reduction in staining of glomerular polyanion, both in the LRE and LRI and swelling and separation of the GBM, occurred in AGBM-treated dogs with severe or mild proteinuria. These events obviously reflect the disturbance in the size and charge selectivity of the GBM.
Loss of glomerular ASS and fusion of epithelial foot processes are often seen in glomerulonephritis with proteinuria. The relationship of epithelial foot process loss and the reduction of ASS in the GBM is not clear. In this study, ASS in the LRE with fusion of epithelial foot processes were quantitated separately from those in the LRE without fusion of epithelial foot processes. No significant differences in the number of ASS in the LRE in these groups were noted. Thus, the reduction of ASS in the GBM observed in this model was not associated with fusion of epithelial foot processes.
It has been reported that HSPG is the major component of the AS in the GBM (10-12, 33). In this study, a marked loss of ASs was observed on day 7 postinjection. However, there was no significant difference in the intensity of HSPG immunostaining between the AGBM-treated and the NRS-treated groups. This suggests that no significant changes in the other hand, in PAN nephrosis, a loss of HSPG has been associated with the pathogenesis of the nephrotic syndrome (1 8). The noncongruency of the results can be discussed in many aspects. First of all, epitopes toward which anti-HSPG antibody is directed may be different. Another reason for the discordance may be that the nephrotoxic serum neutralizes the charge of HSPG and diminishes the affinity to PEI without decreasing HSPG content. In addition, elucidation of the correlation between glomerular ASS and glomeruli HSPG in nephrotic syndrome must await investigations concerning the degree of sulfation or molecular structure of HSPG.
In summary, we have studied the structural and functional alterations ofcanine anti-GBM nephritis. The fact that a reduction ofglomerular Ass occurred in AGBM-treated dogs with severe or mild proteinuria raises the possibility that alterations in glomerular ASS may play a role in the pathogenesis of proteinuria in canine anti-GBM nephritis.
